Drug Development
Review focused on regulatory issues for plant-made pharmaceuticals and vaccines
Published in Vaccine Weekly, January 25th, 2006
According to the review from the United States, "Recombinant plant systems potentially offer economic alternatives to produce large amounts of pharmaceutical proteins, including those used in subunit vaccines. Plant systems also provide a convenient oral delivery option, overcoming the cost and inconvenience of purification and injections."
"The production of pharmaceutical proteins in transgenic plants is tightly regulated, with the U.S. Department of Agriculture focusing on containment of recombinant material and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-01-25)
More Articles from Vaccine Weekly
- Anthrax Vaccine
Mice immunized with chloroplast-derived anthrax antigen survive lethal challenge - Malaria Vaccine
Epitopes delivered by polymeric linear peptides protect against malaria - Meningitis Vaccine
N. meningitidis conjugate vaccine induces protective antibodies - Trichomoniasis Vaccine
Proteinase plus adjuvant prevent Trichomonas genital infections - Tularemia Vaccine
Attenuated Francisella tularensis mutant is an effective live vaccine - Adenovirus Vaccine
Review focused on inactivating antiviral responses during adenovirus infection - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
